Cold Plasma is increasingly becoming an innovative non-thermal option that is widely used within American healthcare facilities, food industry, and semiconductors through the use of partially ionized gas to destroy cell membrane structures of microorganisms without thermal effects on the neighboring tissues and substances. Non-chemical antimicrobial properties of cold plasma technology play an essential role in addressing increasing problems of antibiotics resistance within American healthcare system.
The new development has altered decontamination procedures within American industrial sectors. Cold Plasma products are found effective in treating chronic wounds, sterilization of surgery sites, and dental treatment; also, cold plasma technologies are used in food industry as an alternative to chemical preservatives in connection with American tendency towards clean label products. The transition to plasma treatment in semiconductor industry is also promoting usage of cold plasma technology.
The U.S. Cold Plasma Market was valued at approximately USD 95.07 million in 2025 and is projected to reach around USD 369.18 million by 2035, driven by advanced healthcare facility adoption, semiconductor manufacturing scale-up, and FDA regulatory pathways supporting clinical device approvals. Globally, the Cold Plasma Market was valued at USD 289.06 million in 2025 and is expected to reach USD 1,138.49 million by 2035, expanding at a CAGR of 14.73% during the forecast period of 2026–2035.
Gain Actionable Intelligence on the Cold Plasma Market – Request a Sample Report
U.S. Cold Plasma Market Analysis
The U.S. stands out as the largest national cold plasma market on a global level due to its state-of-the-art ecosystem of innovations in the field of medical devices and progressive FDA regulations related to advanced medical devices including cold plasma wound care devices. Such regulatory clarity helps drive fast commercialization of cold plasma technology in the U.S. healthcare facilities.
Increased semiconductor production has been marked out as one of the key drivers of growth in the U.S. market. Increased demand for cold plasma surface treatment in advanced chip production is driven by the concentration of semiconductor fabrication plants in Arizona, Texas, and Ohio under CHIPS Act investments program.
The innovation activities of research institutions also drive growth in the U.S. market. Cold plasma research institutions based in the U.S., including MIT, Johns Hopkins University, and Drexel Plasma Institute, are driving the development of evidence base necessary for commercialization of cold plasma products in the healthcare segment.
Top 5 Leading Cold Plasma Companies
1. Adtec Healthcare Limited
Adtec Healthcare Limited is one of the leading companies for development of medical devices using clinical cold plasma. The company has an increasing portfolio of clinical cold plasma medical devices that are relevant in terms of applications for wound management for American medical practitioners.
By 2025, Adtec Healthcare was continuing to expand its portfolio of clinical cold plasma wound management medical devices with the applicator designs for diabetic ulcers and post-surgery wounds.
2. Relyon Plasma GmbH
Relyon Plasma GmbH is an innovator company that uses the technology of atmospheric pressure plasma and caters to industrial surface treatments suitable for American automotive industry and electronic manufacturing. The advanced and precise systems of plasma have helped the company broaden its market of industrial cold plasma beyond healthcare.
The year 2025 saw the introduction of advanced piezobrush and atmospheric pressure plasma jet systems catering to industrial surface treatment of American automotive adhesive bonding and electronics PCB cleaning.
3. Enercon Industries Corporation
Enercon Industries Corporation is one of the prominent providers of atmospheric plasma treatment systems, which cater to the North American market in the field of food and consumer packaged goods. These products help meet increasing customer demand for plasma-treated packaging surfaces, which have better printing and sealing properties.
In 2024, Enercon released new atmospheric plasma treatment systems for flexible packaging and labels that meet the demand in America for chemical-free surface treatment systems for packaging production.
4. Plasmatreat GmbH
Plasmatreat GmbH is a world-renowned manufacturer of industrial atmospheric plasma technology that holds significant importance for automotive and electronics manufacturing companies in America that require surface activation and coating adhesion.
With continuous innovations in atmospheric plasma surface treatment technology, Plasmatreat GmbH has been playing an increasingly important role in helping American manufacturers achieve chemical-free solutions for coating adhesion, cleaning, and surface preparation.
5. Apyx Medical Corporation
Apyx Medical Corporation is an American company specialized in plasma-based surgical and cosmetic devices technology. The innovative use of plasma energy technology by the company plays a role in the development of the growing healthcare industry in America.
The continuous effort of Apyx Medical Corporation in the field of plasma-based medical devices technology is a sign that it belongs to the list of innovators in the American healthcare sector.
What the Future of the Cold Plasma Market Holds
The future of cold plasma market will see technological advancements in portable and energy efficient cold plasma devices, resulting in commercial success of cold plasma products in healthcare, industrial and consumer applications. Increasing investments from governments and research institutes will drive applications in water purification, agriculture and environmental remediation.
There is a promising future in agricultural applications, where plasma-activated water and seed treatment systems have shown remarkable increases in crop yield with lower pesticide needs. Novel applications in oncology include the potential cytotoxic activity of cold plasma against cancerous cells in pre-clinical studies that can drive the healthcare application segment forward if successful clinically.
North America accounted for around 35% of global cold plasma revenues in 2025 on the basis of an advanced medical device market and growth in semiconductors manufacturing in the United States. This will ensure that the US remains the largest market for cold plasma through 2035 and beyond.
